You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
义翘神州(301047.SZ)首日上市收涨68.41% 换手率50.15%
格隆汇 08-16 15:12
格隆汇8月16日丨“重组蛋白一哥”义翘神州(301047.SZ)今日首日上市,盘中一度涨104.82%报599.96元,最终收涨68.41%报493.32元,成交45.18亿元,换手率50.15%,最新市值335亿元。该股发行价格292.92元/股,超越石头科技,刷新了A股史上的发行价最高纪录。义翘神州主要从事重组蛋白、抗体、cDNA克隆、ELISA试剂盒等的研发与生产。作为新冠疫情受益的生物制药企业,义翘神州2020年度业绩暴增,招股书显示,义翘神州2020年度营收15.96亿元,较2019年增长782.77%,净利润11.28亿元,同比增长超2996%,其中新冠病毒相关产品收入占当期营业收入的比例为84%。值得关注的是,2020年,义翘神州以96.88%的毛利率超过了大白马贵州茅台91.41%的毛利率。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account